C. �rskov

1.7k total citations · 1 hit paper
7 papers, 1.4k citations indexed

About

C. �rskov is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Surgery. According to data from OpenAlex, C. �rskov has authored 7 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Endocrinology, Diabetes and Metabolism, 4 papers in Molecular Biology and 3 papers in Surgery. Recurrent topics in C. �rskov's work include Diabetes Treatment and Management (6 papers), Diabetes Management and Research (5 papers) and Metabolism, Diabetes, and Cancer (4 papers). C. �rskov is often cited by papers focused on Diabetes Treatment and Management (6 papers), Diabetes Management and Research (5 papers) and Metabolism, Diabetes, and Cancer (4 papers). C. �rskov collaborates with scholars based in Denmark and Germany. C. �rskov's co-authors include Jens J. Holst, Michael A. Nauck, W. Creutzfeldt, N. Kleine, B. Willms, Robert Ritzel, John Christiansen, Birgit Schjoldager, Poul Erik Mortensen and U. T. Hopt and has published in prestigious journals such as Diabetologia, Digestive Diseases and Sciences and Journal of Molecular Medicine.

In The Last Decade

C. �rskov

7 papers receiving 1.3k citations

Hit Papers

Normalization of fasting hyperglycaemia by exogenous gluc... 1993 2026 2004 2015 1993 250 500 750

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
C. �rskov Denmark 6 1.2k 721 433 218 195 7 1.4k
Hans-Christoph Fehmann Germany 14 638 0.5× 563 0.8× 338 0.8× 234 1.1× 102 0.5× 28 1.0k
Lene Hansen Denmark 6 660 0.6× 413 0.6× 203 0.5× 183 0.8× 154 0.8× 6 826
Patricia V. Højberg Denmark 7 771 0.7× 530 0.7× 314 0.7× 72 0.3× 78 0.4× 7 885
Alexander H. Sparre‐Ulrich Denmark 17 845 0.7× 439 0.6× 504 1.2× 207 0.9× 91 0.5× 25 1.1k
D. S. Turner United Kingdom 10 762 0.6× 537 0.7× 253 0.6× 134 0.6× 50 0.3× 13 1.1k
Jakob Werner Germany 5 537 0.5× 300 0.4× 181 0.4× 101 0.5× 103 0.5× 8 654
S. Strobel United States 15 1.0k 0.9× 677 0.9× 276 0.6× 57 0.3× 28 0.1× 16 1.4k
F. Clemente Spain 11 521 0.4× 417 0.6× 312 0.7× 97 0.4× 60 0.3× 12 695
Lene Jessen Denmark 11 450 0.4× 399 0.6× 213 0.5× 106 0.5× 27 0.1× 13 798
Alicia Acitores Spain 12 305 0.3× 213 0.3× 299 0.7× 46 0.2× 83 0.4× 18 567

Countries citing papers authored by C. �rskov

Since Specialization
Citations

This map shows the geographic impact of C. �rskov's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. �rskov with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. �rskov more than expected).

Fields of papers citing papers by C. �rskov

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C. �rskov. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. �rskov. The network helps show where C. �rskov may publish in the future.

Co-authorship network of co-authors of C. �rskov

This figure shows the co-authorship network connecting the top 25 collaborators of C. �rskov. A scholar is included among the top collaborators of C. �rskov based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C. �rskov. C. �rskov is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Ritzel, Robert, C. �rskov, Jens J. Holst, & Michael A. Nauck. (1995). Pharmacokinetic, insulinotropic, and glucagonostatic properties of GLP-1 [7?36 amide] after subcutaneous injection in healthy volunteers. Dose-response-relationships. Diabetologia. 38(6). 720–725. 177 indexed citations
2.
Nauck, Michael A., et al.. (1995). Insulinotropic actions of intravenous glucagon-like peptide-1 (GLP-1) [7?36 amide] in the fasting state in healthy subjects. Acta Diabetologica. 32(1). 13–16. 81 indexed citations
3.
Ritzel, Robert, C. �rskov, Jens J. Holst, & Michael A. Nauck. (1995). Pharmacokinetic, insulinotropic, and glucagonostatic properties of GLP-1 [7?36 amide] after subcutaneous injection in healthy volunteers. Dose-response-relationships. Diabetologia. 38(6). 720–725. 21 indexed citations
4.
Nauck, Michael A., C. �rskov, E. G. Siegel, et al.. (1993). Preserved incretin effect in type 1 diabetic patients with end-stage nephropathy treated by combined heterotopic pancreas and kidney transplantation. Acta Diabetologica. 30(1). 39–45. 36 indexed citations
5.
Nauck, Michael A., N. Kleine, C. �rskov, et al.. (1993). Normalization of fasting hyperglycaemia by exogenous glucagon-like peptide 1 (7-36 amide) in Type 2 (non-insulin-dependent) diabetic patients. Diabetologia. 36(8). 741–744. 904 indexed citations breakdown →
6.
Nauck, Michael A., C. �rskov, E. G. Siegel, et al.. (1992). Basal and nutrient-stimulated pancreatic and gastrointestinal hormone concentrations in type-l-diabetic patients after successful combined pancreas and kidney transplantation. Journal of Molecular Medicine. 70(1). 40–48. 5 indexed citations
7.
Schjoldager, Birgit, Poul Erik Mortensen, John Christiansen, C. �rskov, & Jens J. Holst. (1989). GLP-1 (glucagon-like peptide 1) and truncated GLP-1, fragments of human proglucagon, inhibit gastric acid secretion in humans. Digestive Diseases and Sciences. 34(5). 703–708. 139 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026